43.60PLN-2.24%Mkt Cap: 16.85M $P/E: —10d ago
Urteste S.A. engages in the research and development of diagnostic tests for cancers in Poland. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, bile ducts, stomach, lung, esophagus…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap16.85M $
Enterprise Value16.75M $
Revenue (TTM)631.89K $
Gross Profit-59.26K $
Net Income (TTM)-1.51M $
Revenue/Share0.4392 USD
Last Price43.60 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees38
CountryPL
SectorHealthcare
IndustryBiotechnology
ISINPLURTST00010
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-11.60
EV/Revenue26.51
P/S27.40
P/B2.87
EPS (TTM)-4.94
EPS (Forward)—
52W Range
24.0041% of range72.20
52W High72.20 PLN
52W Low24.00 PLN
Profitability
Gross Margin-1063.64%
Oper. Margin-254.15%
EBITDA Margin-228.50%
Profit Margin-27186.36%
ROE-23.99%
ROA-13.25%
Growth
Revenue Growth-1.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.70M $
CapEx (TTM)3.14M $
FCF Margin-526.77%
FCF Yield-19.75%
Net Debt-755.98K $
Net Debt/EBITDA0.52
Balance Sheet
Debt/Equity0.12
Current Ratio2.58
Quick Ratio2.25
Book Value/Sh15.59 PLN
Cash/Share3.858 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.53M
Float564.91K
Insiders67.24%
Institutions14.34%
Technical
SMA 5045.64 (-4.5%)
SMA 20045.17 (-3.5%)
Beta0.21
S&P 52W Chg19.97%
Avg Vol (30d)753
Avg Vol (10d)478
Technical Indicators
RSI (14)47.9
MACD0.1333
MACD Signal0.2523
MACD Hist.-0.1189
BB Upper48.43 PLN
BB Middle44.81 PLN
BB Lower41.20 PLN
BB Width16.14%
ATR (14)3.349 PLN
Vol Ratio (20d)0.12x